Genetically Modified Viruses Successfully Treat Severely Infected Cystic Fibrosis Patient

According to a story from ArcaMax, history was recently made when a 15 year old teen with a severe "superbug" case of Mycobacterium abscessus infection was successfully treating using specially modified…

Continue Reading Genetically Modified Viruses Successfully Treat Severely Infected Cystic Fibrosis Patient
Findings From Latest Trial Could Herald Progress in Developing a Treatment for Huntington’s Disease
470906 / Pixabay

Findings From Latest Trial Could Herald Progress in Developing a Treatment for Huntington’s Disease

According to a story from Biopharma Dive, an investigational therapy for Huntington's disease that is in development could be the first step in the implementation of the first-ever disease modifying…

Continue Reading Findings From Latest Trial Could Herald Progress in Developing a Treatment for Huntington’s Disease
Duchenne Muscular Dystrophy Patient That Admired Stephen Hawking Passed Away During Exams…With Close to Perfect Scores
HarinathR / Pixabay

Duchenne Muscular Dystrophy Patient That Admired Stephen Hawking Passed Away During Exams…With Close to Perfect Scores

According to a story from m.dailyhunt.in, Vinayak Sreedhar, an Indian student with Duchenne muscular dystrophy, passed away in the midst of taking his exams. Vinayak was a driven and highly…

Continue Reading Duchenne Muscular Dystrophy Patient That Admired Stephen Hawking Passed Away During Exams…With Close to Perfect Scores
2019 Marks the 10 Year Anniversary of the Multiple Sclerosis Association of America’s Art Showcases
Skitterphoto / Pixabay

2019 Marks the 10 Year Anniversary of the Multiple Sclerosis Association of America’s Art Showcases

According to a story from Multiple Sclerosis News Today, 2019 is the tenth year that the Multiple Sclerosis Association of America (MSAA) has conducted its Art Showcases initiative. The program…

Continue Reading 2019 Marks the 10 Year Anniversary of the Multiple Sclerosis Association of America’s Art Showcases
Family Faces Deportation from Australia Because Son’s Cystic Fibrosis Would be a “Burden on Taxpayers”
pattyjansen / Pixabay

Family Faces Deportation from Australia Because Son’s Cystic Fibrosis Would be a “Burden on Taxpayers”

According to a story from The Irish Times, a couple's application for permanent residency in Australia has been rejected twice now following an appeal. Anthony and Christine Hyde, along with…

Continue Reading Family Faces Deportation from Australia Because Son’s Cystic Fibrosis Would be a “Burden on Taxpayers”
Possible Treatment for Paroxysmal Nocturnal Hemoglobinuria Recommended for Marketing Approval in the EU
pixel2013 / Pixabay

Possible Treatment for Paroxysmal Nocturnal Hemoglobinuria Recommended for Marketing Approval in the EU

According to a story from Market Screener, the biopharmaceutical company Alexion Pharmaceuticals has recently announced some encouraging news regarding the status for ravulizumab (marketed as ULTOMIRIS) in the EU. The…

Continue Reading Possible Treatment for Paroxysmal Nocturnal Hemoglobinuria Recommended for Marketing Approval in the EU
Innovative New Test Could Allow for Inflammatory Bowel Disease Patients to Receive More Personalized Treatment
WolfBlur / Pixabay

Innovative New Test Could Allow for Inflammatory Bowel Disease Patients to Receive More Personalized Treatment

According to a story from EurekAlert!, a team of scientists affiliated with the University of Cambridge have pioneered a new test that could herald a new development in the treatment…

Continue Reading Innovative New Test Could Allow for Inflammatory Bowel Disease Patients to Receive More Personalized Treatment

Evidence Suggests The Spinal Muscular Atrophy Gene Therapy Could Help all Patients Regardless of Severity

According to a story from BNN Bloomberg, data from three studies suggest that Zolgensma, a gene therapy for spinal muscular atrophy developed by Novartis, could be useful to all patients…

Continue Reading Evidence Suggests The Spinal Muscular Atrophy Gene Therapy Could Help all Patients Regardless of Severity
As Gene Therapy Becomes a Reality, Spark Therapeutics Looks at Challenges That Still Remain
geralt / Pixabay

As Gene Therapy Becomes a Reality, Spark Therapeutics Looks at Challenges That Still Remain

According to a story from BioPharma Dive, the advent of gene therapy development at Spark Therapeutics has been five years in the making. At this juncture, it has been nearly…

Continue Reading As Gene Therapy Becomes a Reality, Spark Therapeutics Looks at Challenges That Still Remain
Clinical Trial for Experimental Centronuclear Myopathy Drug Given the Green Light
WikimediaImages / Pixabay

Clinical Trial for Experimental Centronuclear Myopathy Drug Given the Green Light

According to a story from BioSpace, the drug development company Dynacure recently released an announcement in which the company stated that its application for a Phase 1/2 clinical trial had…

Continue Reading Clinical Trial for Experimental Centronuclear Myopathy Drug Given the Green Light
After Neurofibromatosis Type 2 Prevented her From Getting Pregnant, her Twin Offered to Serve as a Surrogate
Free-Photos / Pixabay

After Neurofibromatosis Type 2 Prevented her From Getting Pregnant, her Twin Offered to Serve as a Surrogate

According to a story from KTVZ, Jill Noe and Whitney Bliesner have always shared a special bond. They are twins, now 34 years old. Despite their closeness, they do share…

Continue Reading After Neurofibromatosis Type 2 Prevented her From Getting Pregnant, her Twin Offered to Serve as a Surrogate
Could This Experimental Therapy be a Breakthrough for Genetic Amyotrophic Lateral Sclerosis?
NeuPaddy / Pixabay

Could This Experimental Therapy be a Breakthrough for Genetic Amyotrophic Lateral Sclerosis?

According to a story from fox43.com, an experimental therapy for the genetic form of amyotrophic lateral sclerosis (ALS) has been termed "game changing." A study that will soon be presented…

Continue Reading Could This Experimental Therapy be a Breakthrough for Genetic Amyotrophic Lateral Sclerosis?

Vascular Ehlers-Danlos Syndrome Patient Data Released Following Study

According to a story from globenewswire.com, the pharmaceutical company Acer Therapeutics recently announced the release of data from a long-term observational study of patients with vascular Ehlers-Danlos syndrome (vEDS). All…

Continue Reading Vascular Ehlers-Danlos Syndrome Patient Data Released Following Study